AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] VolitionRX Limited Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

On 08/05/2025, VolitionRx Ltd. (VNRX) director Guy Archibald Innes filed Form 4 reporting the purchase of 78,125 common shares at $0.64 per share, executed through the company’s registered direct offering. The transaction lifts his direct holding to 966,814 shares.

The filing also lists significant indirect ownership: 1,400,000 shares held by The Innes Family Bare Trust 2023 (where Innes is trustee), 356,000 shares held by The Dill Faulkes Educational Trust Ltd., and a combined 618,014 shares registered in the names of his son (309,006) and daughter (309,008). Innes shares voting/dispositive control over these blocks and disclaims beneficial ownership of the DFET position beyond any pecuniary interest.

No derivative securities were reported, and the form was signed on 08/06/2025.

Il 08/05/2025, il direttore di VolitionRx Ltd. (VNRX), Guy Archibald Innes, ha presentato il Modulo 4 segnalando l'acquisto di 78.125 azioni ordinarie a $0,64 ciascuna, eseguito tramite l'offerta diretta registrata della società. Questa operazione porta la sua detenzione diretta a 966.814 azioni.

La dichiarazione riporta inoltre una significativa proprietà indiretta: 1.400.000 azioni detenute da The Innes Family Bare Trust 2023 (dove Innes è trustee), 356.000 azioni detenute da The Dill Faulkes Educational Trust Ltd., e un totale combinato di 618.014 azioni intestate a suo figlio (309.006) e a sua figlia (309.008). Innes condivide il controllo di voto/dispositivo su questi blocchi e nega la titolarità effettiva della posizione DFET oltre a qualsiasi interesse pecuniario.

Non sono stati segnalati titoli derivati e il modulo è stato firmato il 08/06/2025.

El 08/05/2025, el director de VolitionRx Ltd. (VNRX), Guy Archibald Innes, presentó el Formulario 4 informando la compra de 78,125 acciones ordinarias a $0.64 por acción, realizada a través de la oferta directa registrada de la compañía. La transacción eleva su participación directa a 966,814 acciones.

La presentación también indica una significativa propiedad indirecta: 1,400,000 acciones en The Innes Family Bare Trust 2023 (donde Innes es fideicomisario), 356,000 acciones en The Dill Faulkes Educational Trust Ltd., y un total combinado de 618,014 acciones registradas a nombre de su hijo (309,006) y su hija (309,008). Innes comparte el control de voto/dispositivo sobre estos bloques y renuncia a la propiedad beneficiaria de la posición DFET más allá de cualquier interés pecuniario.

No se reportaron valores derivados y el formulario fue firmado el 08/06/2025.

2025ë…� 8ì›� 5ì�, VolitionRx Ltd.(VNRX)ì� ì´ì‚¬ Guy Archibald Innesê°€ Form 4ë¥� 제출하여 회사ì� ë“±ë¡ ì§ì ‘ 공모ë¥� 통해 주당 $0.64ì—� 78,125 보통주를 매수했다ê³� 보고했습니다. ì� 거래ë¡� ê·¸ì˜ ì§ì ‘ 보유 ì£¼ì‹ ìˆ˜ê°€ 966,814주로 ì¦ê°€í–ˆìŠµë‹ˆë‹¤.

신고서ì—ëŠ� ë˜í•œ ìƒë‹¹í•� ê°„ì ‘ 소유ê¶�ì� 명시ë˜ì–´ 있습니다: Innesê°€ 수íƒìžì¸ The Innes Family Bare Trust 2023ê°€ 보유í•� 1,400,000ì£�, The Dill Faulkes Educational Trust Ltd.ê°€ 보유í•� 356,000ì£�, 그리ê³� ê·¸ì˜ ì•„ë“¤(309,006ì£�)ê³� ë”�(309,008ì£�) 명ì˜ë¡� 등ë¡ë� ì´� 618,014주가 í¬í•¨ë©ë‹ˆë‹�. InnesëŠ� ì� 지분들ì—� 대í•� ì˜ê²°ê¶� ë°� ì²˜ë¶„ê¶Œì„ ê³µìœ í•˜ë©°, DFET ì§€ë¶„ì— ëŒ€í•� 실질ì � ì†Œìœ ê¶Œì€ ê¸ˆì „ì � ì´ìµì� 제외하고 ë¶€ì¸í•˜ê³� 있습니다.

íŒŒìƒ ì¦ê¶Œì€ ë³´ê³ ë˜ì§€ 않았으며, 서류ëŠ� 2025ë…� 8ì›� 6ì¼ì— 서명ë˜ì—ˆìŠµë‹ˆë‹�.

Le 08/05/2025, le directeur de VolitionRx Ltd. (VNRX), Guy Archibald Innes, a déposé le formulaire 4 déclarant l'achat de 78 125 actions ordinaires au prix de 0,64 $ par action, réalisé via l'offre directe enregistrée de la société. Cette transaction porte sa participation directe à 966 814 actions.

Le dépôt mentionne également une importante possession indirecte : 1 400 000 actions détenues par The Innes Family Bare Trust 2023 (dont Innes est le fiduciaire), 356 000 actions détenues par The Dill Faulkes Educational Trust Ltd., ainsi qu'un total combiné de 618 014 actions enregistrées au nom de son fils (309 006) et de sa fille (309 008). Innes partage le contrôle de vote/disposition sur ces blocs et décline la propriété bénéficiaire de la position DFET au-delà de tout intérêt pécuniaire.

Aucun titre dérivé n’a été signalé, et le formulaire a été signé le 08/06/2025.

Am 08.05.2025 reichte VolitionRx Ltd. (VNRX) Direktor Guy Archibald Innes das Formular 4 ein und meldete den Kauf von 78.125 Stammaktien zu je $0,64, ausgeführt über das registrierte Direktangebot der Gesellschaft. Die Transaktion erhöht seinen direkten Anteil auf 966.814 Aktien.

Die Meldung listet zudem eine bedeutende indirekte Beteiligung auf: 1.400.000 Aktien, gehalten vom The Innes Family Bare Trust 2023 (wo Innes Treuhänder ist), 356.000 Aktien vom The Dill Faulkes Educational Trust Ltd. und insgesamt 618.014 Aktien, die auf die Namen seines Sohnes (309.006) und seiner Tochter (309.008) registriert sind. Innes teilt sich die Stimm- und Verfügungsgewalt über diese Anteile und weist eine wirtschaftliche Eigentümerschaft an der DFET-Position über sein finanzielles Interesse hinaus zurück.

Es wurden keine Derivate gemeldet, und das Formular wurde am 08.06.2025 unterschrieben.

Positive
  • None.
Negative
  • None.

Insights

TL;DR � Director bought 78k shares, raising direct stake to ~0.97 M; insider alignment strengthened.

Innes� $0.64 purchase adds roughly $50k of fresh capital and brings his direct ownership to nearly one million shares. Including trusts and family accounts, disclosed beneficial ownership surpasses 2.9 M shares, or a meaningful portion of VolitionRx’s public float. No sales or derivative activity were reported, indicating net accumulation. Insider buying—especially in a financing context—can be interpreted as confidence in forthcoming milestones, though the purchase size is modest relative to total indirect holdings. Overall impact leans positive, signalling alignment with minority shareholders and removing the overhang of insider selling concerns.

Il 08/05/2025, il direttore di VolitionRx Ltd. (VNRX), Guy Archibald Innes, ha presentato il Modulo 4 segnalando l'acquisto di 78.125 azioni ordinarie a $0,64 ciascuna, eseguito tramite l'offerta diretta registrata della società. Questa operazione porta la sua detenzione diretta a 966.814 azioni.

La dichiarazione riporta inoltre una significativa proprietà indiretta: 1.400.000 azioni detenute da The Innes Family Bare Trust 2023 (dove Innes è trustee), 356.000 azioni detenute da The Dill Faulkes Educational Trust Ltd., e un totale combinato di 618.014 azioni intestate a suo figlio (309.006) e a sua figlia (309.008). Innes condivide il controllo di voto/dispositivo su questi blocchi e nega la titolarità effettiva della posizione DFET oltre a qualsiasi interesse pecuniario.

Non sono stati segnalati titoli derivati e il modulo è stato firmato il 08/06/2025.

El 08/05/2025, el director de VolitionRx Ltd. (VNRX), Guy Archibald Innes, presentó el Formulario 4 informando la compra de 78,125 acciones ordinarias a $0.64 por acción, realizada a través de la oferta directa registrada de la compañía. La transacción eleva su participación directa a 966,814 acciones.

La presentación también indica una significativa propiedad indirecta: 1,400,000 acciones en The Innes Family Bare Trust 2023 (donde Innes es fideicomisario), 356,000 acciones en The Dill Faulkes Educational Trust Ltd., y un total combinado de 618,014 acciones registradas a nombre de su hijo (309,006) y su hija (309,008). Innes comparte el control de voto/dispositivo sobre estos bloques y renuncia a la propiedad beneficiaria de la posición DFET más allá de cualquier interés pecuniario.

No se reportaron valores derivados y el formulario fue firmado el 08/06/2025.

2025ë…� 8ì›� 5ì�, VolitionRx Ltd.(VNRX)ì� ì´ì‚¬ Guy Archibald Innesê°€ Form 4ë¥� 제출하여 회사ì� ë“±ë¡ ì§ì ‘ 공모ë¥� 통해 주당 $0.64ì—� 78,125 보통주를 매수했다ê³� 보고했습니다. ì� 거래ë¡� ê·¸ì˜ ì§ì ‘ 보유 ì£¼ì‹ ìˆ˜ê°€ 966,814주로 ì¦ê°€í–ˆìŠµë‹ˆë‹¤.

신고서ì—ëŠ� ë˜í•œ ìƒë‹¹í•� ê°„ì ‘ 소유ê¶�ì� 명시ë˜ì–´ 있습니다: Innesê°€ 수íƒìžì¸ The Innes Family Bare Trust 2023ê°€ 보유í•� 1,400,000ì£�, The Dill Faulkes Educational Trust Ltd.ê°€ 보유í•� 356,000ì£�, 그리ê³� ê·¸ì˜ ì•„ë“¤(309,006ì£�)ê³� ë”�(309,008ì£�) 명ì˜ë¡� 등ë¡ë� ì´� 618,014주가 í¬í•¨ë©ë‹ˆë‹�. InnesëŠ� ì� 지분들ì—� 대í•� ì˜ê²°ê¶� ë°� ì²˜ë¶„ê¶Œì„ ê³µìœ í•˜ë©°, DFET ì§€ë¶„ì— ëŒ€í•� 실질ì � ì†Œìœ ê¶Œì€ ê¸ˆì „ì � ì´ìµì� 제외하고 ë¶€ì¸í•˜ê³� 있습니다.

íŒŒìƒ ì¦ê¶Œì€ ë³´ê³ ë˜ì§€ 않았으며, 서류ëŠ� 2025ë…� 8ì›� 6ì¼ì— 서명ë˜ì—ˆìŠµë‹ˆë‹�.

Le 08/05/2025, le directeur de VolitionRx Ltd. (VNRX), Guy Archibald Innes, a déposé le formulaire 4 déclarant l'achat de 78 125 actions ordinaires au prix de 0,64 $ par action, réalisé via l'offre directe enregistrée de la société. Cette transaction porte sa participation directe à 966 814 actions.

Le dépôt mentionne également une importante possession indirecte : 1 400 000 actions détenues par The Innes Family Bare Trust 2023 (dont Innes est le fiduciaire), 356 000 actions détenues par The Dill Faulkes Educational Trust Ltd., ainsi qu'un total combiné de 618 014 actions enregistrées au nom de son fils (309 006) et de sa fille (309 008). Innes partage le contrôle de vote/disposition sur ces blocs et décline la propriété bénéficiaire de la position DFET au-delà de tout intérêt pécuniaire.

Aucun titre dérivé n’a été signalé, et le formulaire a été signé le 08/06/2025.

Am 08.05.2025 reichte VolitionRx Ltd. (VNRX) Direktor Guy Archibald Innes das Formular 4 ein und meldete den Kauf von 78.125 Stammaktien zu je $0,64, ausgeführt über das registrierte Direktangebot der Gesellschaft. Die Transaktion erhöht seinen direkten Anteil auf 966.814 Aktien.

Die Meldung listet zudem eine bedeutende indirekte Beteiligung auf: 1.400.000 Aktien, gehalten vom The Innes Family Bare Trust 2023 (wo Innes Treuhänder ist), 356.000 Aktien vom The Dill Faulkes Educational Trust Ltd. und insgesamt 618.014 Aktien, die auf die Namen seines Sohnes (309.006) und seiner Tochter (309.008) registriert sind. Innes teilt sich die Stimm- und Verfügungsgewalt über diese Anteile und weist eine wirtschaftliche Eigentümerschaft an der DFET-Position über sein finanzielles Interesse hinaus zurück.

Es wurden keine Derivate gemeldet, und das Formular wurde am 08.06.2025 unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Innes Guy Archibald

(Last) (First) (Middle)
1489 WEST WARM SPRINGS ROAD
SUITE 110

(Street)
HENDERSON NV 89014

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
VOLITIONRX LTD [ VNRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/05/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/05/2025 P 78,125(1) A $0.64 966,814 D
Common Stock 1,400,000 I By The Innes Family Bare Trust 2023(2)
Common Stock 356,000 I By The Dill Faulkes Educational Trust Limited(3)
Common Stock 154,503 I By son
Common Stock 154,503 I By son
Common Stock 154,504 I By daughter
Common Stock 154,504 I By daughter
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Acquired at the offering price in the registered direct offering of Common Stock by VolitionRx.
2. These shares of Common Stock are beneficially owned by The Innes Family Bare Trust 2023, which is a separate legal entity, of which the reporting person is the Trustee, for the benefit of his children.
3. These shares of Common Stock are beneficially owned by The Dill Faulkes Educational Trust Limited ("DFET"), a UK registered charity. The reporting person serves as a director and trustee of DFET and shares voting and dispositive control over these shares but disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Remarks:
/s/ Guy Archibald Innes 08/06/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Volitionrx

NYSE:VNRX

VNRX Rankings

VNRX Latest News

VNRX Latest SEC Filings

VNRX Stock Data

66.55M
83.43M
18.4%
20.49%
0.35%
Medical Devices
In Vitro & in Vivo Diagnostic Substances
United States
HENDERSON